OrphoMed, Inc.

10:15 AM - 10:30 AM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
ORP-101
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2